10 August 2022
Polish Respiratory Society Partnering with MDPI to Publish Advances in Respiratory Medicine
You are accessing a machine-readable page. In order to be human-readable, please install an RSS reader.
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Feature papers represent the most advanced research with significant potential for high impact in the field. A Feature Paper should be a substantial original Article that involves several techniques or approaches, provides an outlook for future research directions and describes possible research applications.
Feature papers are submitted upon individual invitation or recommendation by the scientific editors and must receive positive feedback from the reviewers.
Editor’s Choice articles are based on recommendations by the scientific editors of MDPI journals from around the world. Editors select a small number of articles recently published in the journal that they believe will be particularly interesting to readers, or important in the respective research area. The aim is to provide a snapshot of some of the most exciting work published in the various research areas of the journal.
Original Submission Date Received: .
We are pleased to announce the new partnership between the Polish Respiratory Society, the National Research Institute of Tuberculosis and Lung Diseases, and MDPI, in publishing the journal Advances in Respiratory Medicine (ARM).
ARM offers a forum for research on respiratory medicine, covering allergology, oncology, immunology, and infectious diseases of the respiratory system. With the transfer to MDPI on 1 July 2022, from Via Medica, the open access (CC BY) license is now the standard for all future articles published in ARM. The journal continues to be owned by the Polish Respiration Society and is hosted by MDPI.
MDPI and the Polish Respiratory Society are excited to jointly build on the journal’s more than 100 years of history, which includes pioneering research in the fight against tuberculosis in Poland. Together, we aim to increase the international outlook for Advances in Respiratory Medicine and add to its visibility and impact within major scholarly databases. ARM is indexed for MEDLINE, as well as Scopus, Web of Science (ESCI), and other databases.
We strive to offer an affordable publishing option for medical researchers and practitioners around the globe.
In an Editorial published at the beginning of August 2022, ARM’s Editor-in-Chief, Prof. Dr. Adam Barczyk, detailed his plans for developing the journal into a prime venue in respiratory medicine. MDPI’s well-established editorial platform and processes will offer Prof. Dr. Barczyk, his team of Associate Editors, Prof. Dr. Krzysztof Kuziemski, Dr. Tadeusz Maria Zielonka, Prof. Dr. Sebastian Majewski, and Dr. Monika Franczuk, and the members of the Society all the support needed to reach the journal’s goals.
MDPI currently supports more than 100 learned societies and organizations ranging from affiliations to publishing journals on behalf of the society. As a pioneer in open access publishing with over 25 years’ experience, MDPI is interested in helping societies willing to fully venture into the open access publication model.
Journal Contact:
Amadeusz Bryła
Managing Editor, Advances in Respiratory Medicine
E-Mail
Scholarly Societies Contact:
Carla Aloè
Publisher
E-Mail